318. Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF) in Hispanic/Latinx and Black Participants: Efficacy, Bone and Renal Safety Results from a Pooled Analysis of 7 Clinical Trials

BACKGROUND: People of color are underrepresented in clinical trials. TAF has shown improved renal and bone safety vs. TDF. We pooled 7 studies to evaluate efficacy/safety of TAF vs. TDF for ART initiation/switch in Hispanic/Latinx and Black participants. METHODS: Data from Hispanic/Latinx and Black...

Descripción completa

Detalles Bibliográficos
Autores principales: DeJesus, Edwin, Federico Andrade Villanueva, Jaime, Ramon Arribas Lopez, Jose, Brinson, Cynthia, Crofoot, Gordon, Daar, Eric S, Koenig, Ellen, Podzamczer, Daniel, Ramgopal, Moti, Santana, Jorge, Santiago, Lizette, Tebas, Pablo, Zorrilla, Carmen, Guo, Susan, Liu, Ya-Pei, Zhong, Lijie, Brainard, Diana M, Carter, Christoph C, Temme, Lauren, Das, Moupali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809442/
http://dx.doi.org/10.1093/ofid/ofz360.391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809442/
http://dx.doi.org/10.1093/ofid/ofz360.391

Ejemplares similares